Date of Publication: October 15, 2020 Objectives: HTA Full Report: Reassessment of 10- versus 13-valent Pneumococcal Conjugate Vaccines (PCV) in the Philippines Evidence summary: PCV ES OSEC Approved
Reverse Transcriptase – Polymerase Chain Reaction (RT-PCR)
I. Assessment A. Policy and Research Question Policy Question: Which SARS-CoV-2 PCR test kit brand/s may be procured by the Philippine DOH for detecting COVID19 cases among suspect cases and recovering patients? Research Questions: Market availability and implementation Performance: Accuracy or Agreement Measures Resource requirements B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. continue reading : Reverse Transcriptase – Polymerase Chain Reaction (RT-PCR)
AMTI uAI-Discover-PNA
I. Assessment A. Policy and Research Question Policy Question: Should the Department of Health accept the donation of the AMTI uAI-Discover-PNA for COVID-19 in the Philippines? Research Questions: B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. Start of Review: Not available. E. End of Review: April 14, 2020 II. Recommendation Evidence summary: AMTI uAI-Discover-PNA Rapid review: Pending continue reading : AMTI uAI-Discover-PNA
Huawei Cloud AI-Assisted Diagnosis
I. Assessment A. Policy and Research Question Policy Question: Should the Department of Health participate in the proof of concept study for Huawei Cloud Artificial Intelligence (AI)-Assisted Diagnosis for COVID-19 in the Philippines? Research Questions: Not available B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. Start of Review: Not available. E. End of Review: April continue reading : Huawei Cloud AI-Assisted Diagnosis